| duruöz hand index |
315 |
| factor analysis |
315 |
| lateral epicondylitis |
315 |
| reliability |
315 |
| validity |
315, 351 |
| dsm-5 |
326 |
| personality disorder |
326 |
| quality of life |
326 |
| systemic lupus erythematosus |
326, 361 |
| cytokines |
335 |
| monocytes |
335 |
| osteoarthritis |
335 |
| synovial fluid |
335 |
| interferon gamma release test |
344 |
| latent tuberculosis |
344 |
| mycobacterium tuberculosis |
344 |
| takayasu arteritis |
344 |
| tuberculosis |
344 |
| head and neck cancer |
351 |
| sjögren syndrome |
351 |
| xerostomia |
351 |
| low disease activity |
361 |
| pregnancy |
361 |
| pregnancy outcome |
361 |
| remission |
361 |
| function |
375 |
| grip strength |
375 |
| hand osteoarthritis |
375 |
| pain |
375 |
| cardiac autophagy inhibitory factor |
383 |
| human fibroblast-like synoviocytes |
383 |
| mir-20a |
383 |
| precursor |
383 |
| rheumatoid arthritis |
383, 393, 466 |
| apoptosis |
393 |
| autophagy |
393 |
| fibroblast-like synoviocytes |
393 |
| grape seed proanthocyanidin extract |
393 |
| capillaries |
404 |
| capillaroscopy |
404 |
| nailfold video-capillaroscopy |
404 |
| polycythemia vera |
404 |
| adolescents |
411 |
| juvenile idiopathic arthritis |
411 |
| transition readiness assessment |
411 |
| transition readiness assessment questionnaire |
411 |
| complement factor h |
417 |
| factor h autoantibodies |
417 |
| juvenile-onset systemic lupus erythematosus |
417 |
| nephritis |
417 |
| antisynthetase syndrome |
424 |
| dermatomyositis |
424 |
| myositis |
424 |
| outcomes |
424 |
| anakinra |
435 |
| autoinflammatory diseases |
435 |
| familial mediterranean fever |
435 |
| macrophage activation syndrome |
435 |
| systemic-onset juvenile idiopathic arthritis |
435 |
| aerobic exercise |
444 |
| fibromyalgia |
444 |
| resistance exercise |
444 |
| stretching exercise |
444 |
| adult immunization |
456 |
| autoimmune inflammatory rheumatic disease |
456 |
| covid-19 |
456 |
| immunosuppressive |
456 |
| vaccine |
456 |
| ankylosing spondylitis |
466 |
| bone morphogenetic protein |
466 |
| bone turnover |
466 |
| disease activity |
466 |
